Literature DB >> 25605735

Mouse cytotoxic T cell-derived granzyme B activates the mitochondrial cell death pathway in a Bim-dependent fashion.

Elena Catalán1, Paula Jaime-Sánchez1, Nacho Aguiló2, Markus M Simon3, Christopher J Froelich4, Julián Pardo5.   

Abstract

Cytotoxic T cells (Tc) use perforin and granzyme B (gzmB) to kill virus-infected cells and cancer cells. Recent evidence suggests that human gzmB primarily induces apoptosis via the intrinsic mitochondrial pathway by either cleaving Bid or activating Bim leading to the activation of Bak/Bax and subsequent generation of active caspase-3. In contrast, mouse gzmB is thought to predominantly induce apoptosis by directly processing pro-caspase-3. However, in certain mouse cell types gzmB-mediated apoptosis mainly occurs via the mitochondrial pathway. To investigate whether Bim is involved under the latter conditions, we have now employed ex vivo virus-immune mouse Tc that selectively kill by using perforin and gzmB (gzmB(+)Tc) as effector cells and wild type as well as Bim- or Bak/Bax-deficient spontaneously (3T9) or virus-(SV40) transformed mouse embryonic fibroblast cells as targets. We show that gzmB(+)Tc-mediated apoptosis (phosphatidylserine translocation, mitochondrial depolarization, cytochrome c release, and caspase-3 activation) was severely reduced in 3T9 cells lacking either Bim or both Bak and Bax. This outcome was related to the ability of Tc cells to induce the degradation of Mcl-1 and Bcl-XL, the anti-apoptotic counterparts of Bim. In contrast, gzmB(+)Tc-mediated apoptosis was not affected in SV40-transformed mouse embryonic fibroblast cells lacking Bak/Bax. The data provide evidence that Bim participates in mouse gzmB(+)Tc-mediated apoptosis of certain targets by activating the mitochondrial pathway and suggest that the mode of cell death depends on the target cell. Our results suggest that the various molecular events leading to transformation and/or immortalization of cells have an impact on their relative resistance to the multiple gzmB(+)Tc-induced death pathways.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apoptosis; B Cell Lymphoma 2 (Bcl-2) Family; Cancer; Cancer Therapy; Immunotherapy; T Cell

Mesh:

Substances:

Year:  2015        PMID: 25605735      PMCID: PMC4358112          DOI: 10.1074/jbc.M114.631564

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress.

Authors:  Michael Boyce; Kevin F Bryant; Céline Jousse; Kai Long; Heather P Harding; Donalyn Scheuner; Randal J Kaufman; Dawei Ma; Donald M Coen; David Ron; Junying Yuan
Journal:  Science       Date:  2005-02-11       Impact factor: 47.728

Review 2.  The granule pathway of programmed cell death.

Authors:  Philip G Ashton-Rickardt
Journal:  Crit Rev Immunol       Date:  2005       Impact factor: 2.214

3.  Disruption of Mcl-1.Bim complex in granzyme B-mediated mitochondrial apoptosis.

Authors:  Jie Han; Leslie A Goldstein; Brian R Gastman; Asaf Rabinovitz; Hannah Rabinowich
Journal:  J Biol Chem       Date:  2005-02-15       Impact factor: 5.157

Review 4.  Natural innate and adaptive immunity to cancer.

Authors:  Matthew D Vesely; Michael H Kershaw; Robert D Schreiber; Mark J Smyth
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

Authors:  P Li; D Nijhawan; I Budihardjo; S M Srinivasula; M Ahmad; E S Alnemri; X Wang
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

6.  Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis.

Authors:  Magali Herrant; Arnaud Jacquel; Sandrine Marchetti; Nathalie Belhacène; Pascal Colosetti; Frédéric Luciano; Patrick Auberger
Journal:  Oncogene       Date:  2004-10-14       Impact factor: 9.867

7.  Degradation of Mcl-1 by granzyme B: implications for Bim-mediated mitochondrial apoptotic events.

Authors:  Jie Han; Leslie A Goldstein; Brian R Gastman; Christopher J Froelich; Xiao-Ming Yin; Hannah Rabinowich
Journal:  J Biol Chem       Date:  2004-03-10       Impact factor: 5.157

8.  Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B.

Authors:  A J Darmon; D W Nicholson; R C Bleackley
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

9.  Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis.

Authors:  Julián Pardo; Alberto Bosque; Reina Brehm; Reinhard Wallich; Javier Naval; Arno Müllbacher; Alberto Anel; Markus M Simon
Journal:  J Cell Biol       Date:  2004-11-08       Impact factor: 10.539

10.  Combined loss of proapoptotic genes Bak or Bax with Bim synergizes to cause defects in hematopoiesis and in thymocyte apoptosis.

Authors:  Jack Hutcheson; John C Scatizzi; Emily Bickel; Nathaniel J Brown; Philippe Bouillet; Andreas Strasser; Harris Perlman
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

View more
  10 in total

Review 1.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

Review 2.  Mannose-6-phosphate receptor: a novel regulator of T cell immunity.

Authors:  Anjuman Ara; Khawaja Ashfaque Ahmed; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2018-05-16       Impact factor: 11.530

Review 3.  All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity.

Authors:  Ariel Ramírez-Labrada; Cecilia Pesini; Llipsy Santiago; Sandra Hidalgo; Adanays Calvo-Pérez; Carmen Oñate; Alejandro Andrés-Tovar; Marcela Garzón-Tituaña; Iratxe Uranga-Murillo; Maykel A Arias; Eva M Galvez; Julián Pardo
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

Review 4.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

5.  Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity.

Authors:  Yong Sun Lee; In Jun Yeo; Ki Cheon Kim; Sang-Bae Han; Jin Tae Hong
Journal:  Front Immunol       Date:  2019-06-18       Impact factor: 7.561

Review 6.  Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance.

Authors:  Lisa C Holthof; Tuna Mutis
Journal:  Cancers (Basel)       Date:  2020-04-17       Impact factor: 6.639

Review 7.  Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity.

Authors:  Karoliina Tuomela; Ashley R Ambrose; Daniel M Davis
Journal:  Front Immunol       Date:  2022-03-23       Impact factor: 7.561

Review 8.  Targeting the Microenvironment for Treating Multiple Myeloma.

Authors:  Peter Neumeister; Eduard Schulz; Katrin Pansy; Marta Szmyra; Alexander Ja Deutsch
Journal:  Int J Mol Sci       Date:  2022-07-10       Impact factor: 6.208

Review 9.  Positive and negative functions of B lymphocytes in tumors.

Authors:  Meng Shen; Qian Sun; Jian Wang; Wei Pan; Xiubao Ren
Journal:  Oncotarget       Date:  2016-08-23

10.  Cell death induced by cytotoxic CD8+ T cells is immunogenic and primes caspase-3-dependent spread immunity against endogenous tumor antigens.

Authors:  Paula Jaime-Sanchez; Iratxe Uranga-Murillo; Nacho Aguilo; Sofia C Khouili; Maykel A Arias; David Sancho; Julian Pardo
Journal:  J Immunother Cancer       Date:  2020-04       Impact factor: 13.751

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.